J&J Vaccine Study Resumes in South Africa
A research study in South Africa further evaluating Johnson & Johnson’s COVID-19 vaccine in the field will resume on Wednesday, the health ministry said, after the study was paused over rare cases of blood clots in people given the vaccine. During the pause, it had been established that there is a one in a million…